{
  "compound": "Dronabinol (Marinol)",
  "condition": "TOURETTE_SYNDROME",
  "effect_size": "Large (40% reduction)",
  "study_type": "RCT",
  "source": "NORML:TS_RCT_004",
  "participants": "8 adults with treatment-resistant TS",
  "year": 2016,
  "notes": "Dronabinol for Tourette Syndrome: US Pilot Trial",
  "confidence": "medium",
  "abstract": "Dronabinol: YGTSS reduced 40% from baseline; 6/8 (75%) achieved clinically significant improvement"
}